To evaluate the effect of MD and AA+MD on key signaling molecules commonly altered in GBM, we performed immunoblot analysis of Akt and JNK activity in U251 cells treated with increasing MD concentrations (20–60 μM), a single AA concentration (1 mM), and their combinations (Figure 2a). The gene discussed is MAPK8; the disease is glioblastoma.